Menu

非布司他治疗效果

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

How effective is the treatment? Experts explain that febuxostat is very effective in treating gout and can quickly reduce blood uric acid levels. Febuxostat is a selective xanthine oxidase inhibitor that has a specific uric acid-lowering effect without affecting other metabolic processes in the body.

As a new gout drug, febuxostat has quickly occupied the gout market due to its good therapeutic effect and low side effects since its launch, becoming the first choice for most patients. Febuxostat has a very rapid effect in lowering blood uric acid. Generally, if the oral medication is 40 mg per day, the blood uric acid level can reach the target in 1-2 weeks. However, due to the rapid reduction of blood uric acid, it is easy to induce an acute gouty arthritis attack. Therefore, it is not recommended to increase the dosage of febuxostat. Patients are generally required to take 20 mg orally per day at the beginning.

Febuxostat is a new type of selective non-purine xanthine oxidase (XO) inhibitor. Its main ingredient is febuxostat. The drug was approved by the U.S. Food and Drug Administration (FDA) for marketing in the United States in February 2009. In 2010, it was launched in France, the United Kingdom, Germany and other countries. Febuxostat is a newly developed drug, and at the same dose, febuxostat has a stronger effect in reducing blood uric acid. Therefore, when it comes to the choice of acid-lowering drugs for gout, many patients prefer febuxostat.

Currently, there are more than 20 phase III clinical trials of febuxostat that have been conducted or are ongoing in my country. However, because febuxostat has been on the market for a short time in China, there are few reports on clinical applications and adverse reactions after use. Although febuxostat is more effective in treating gout, it does not mean that it does not have any side effects. Febuxostat still has risks of allergic reactions, liver and kidney toxicity, and cardiovascular adverse events, so patients should closely monitor changes in liver and kidney function during use. If a patient experiences a serious adverse event after taking it, he/she needs to communicate with the attending doctor in time for timely treatment.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。